top of page

I'm a paragraph. Click here to add your own text and edit me. It's easy.

J&J innovation labs logo
About us

About Us

Oriel Research Therapeutics (ORT) is a bioinformatics company that provides services both for harmonized real-world patients’ derived genomic data, AI based model development, and early detection tests for cancer and other diseases using its AI-based platform.

ORT's technology utilizes a state-of-the-art cloud-based software platform, which processes large omic, like gene expressions, and clinical data to build the ORT database. The database is processed with proprietary Artificial Intelligence/Machine Learning (Al/ML) models.

The ORT database includes over 1 million RNA-seq profiles from in-vivo and in-vitro patients’ samples with matching clinical data.

Oriel Research Therapeutics allows easy access to its large-scale, harmonized, real-world data (RWD) and to its proprietary pipelines to allow a quick adoption of evidence-based hypotheses for diagnosis, therapy matching, and target development.


ORT is a J&J innovation lab company and is located in Cambridge, MA

Oriel Research Therapeutics Eila Arich-Landkof, ORT, CEO

Eila Arich ME

Founder, CEO

Technion, Broad Institute, MGH, Whitehead Institute,


Oriel Research Therapeutics Noam Shoresh, PhD

Noam Shoresh PhD

Science, Bioinformatics

Harvard Medical School, Broad Institute, MGH, The Hebrew University

bottom of page